Dr Alan Gary Friedman, OD - Medicare Optometrist in Hanover, MD

Dr Alan Gary Friedman, OD is a medicare enrolled "Optometrist" provider in Hanover, Maryland. He went to Pennsylvania College Of Optometry and graduated in 1980 and has 44 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Myeyedr Optometry Of Maryland Llc and his current practice location is 7550 Teague Rd, Hanover, Maryland. You can reach out to his office (for appointments etc.) via phone at (410) 799-8067.

Dr Alan Gary Friedman is licensed to practice in Maryland (license number TA0788) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1386660348.

Contact Information

Dr Alan Gary Friedman, OD
7550 Teague Rd,
Hanover, MD 21076-1339
(410) 799-8067
(410) 799-8414



Healthcare Provider's Profile

Full NameDr Alan Gary Friedman
GenderMale
SpecialityOptometry
Experience44 Years
Location7550 Teague Rd, Hanover, Maryland
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Alan Gary Friedman attended and graduated from Pennsylvania College Of Optometry in 1980
  NPI Data:
  • NPI Number: 1386660348
  • Provider Enumeration Date: 07/14/2006
  • Last Update Date: 01/30/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 7517256969
  • Enrollment ID: I20160525001492

Medical Identifiers

Medical identifiers for Dr Alan Gary Friedman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1386660348NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist TA0788 (Maryland)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Myeyedr Optometry Of Maryland Llc600203762961

News Archive

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Psychiatric centres needed for Iraqi children

Psychiatric illness among Iraqi children in Baghdad is such a problem that child psychiatric centres are needed, a new study has found.

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Alan Gary Friedman allows following entities to bill medicare on his behalf.
Provider NameAnnapolis Optometry, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1679717367
PECOS PAC ID: 7911183306
Enrollment ID: O20110519000519

News Archive

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Psychiatric centres needed for Iraqi children

Psychiatric illness among Iraqi children in Baghdad is such a problem that child psychiatric centres are needed, a new study has found.

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

Read more Medical News

› Verified 6 days ago

Provider NameColumbia Optometry Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1124305388
PECOS PAC ID: 1557519139
Enrollment ID: O20120925000082

News Archive

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Psychiatric centres needed for Iraqi children

Psychiatric illness among Iraqi children in Baghdad is such a problem that child psychiatric centres are needed, a new study has found.

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

Read more Medical News

› Verified 6 days ago

Provider NameCanton Crossing Optometry Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1326474263
PECOS PAC ID: 4284863614
Enrollment ID: O20140206000731

News Archive

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Psychiatric centres needed for Iraqi children

Psychiatric illness among Iraqi children in Baghdad is such a problem that child psychiatric centres are needed, a new study has found.

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

Read more Medical News

› Verified 6 days ago

Provider NameMyeyedr Optometry Of Maryland Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1609204437
PECOS PAC ID: 6002037629
Enrollment ID: O20141024000821

News Archive

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Psychiatric centres needed for Iraqi children

Psychiatric illness among Iraqi children in Baghdad is such a problem that child psychiatric centres are needed, a new study has found.

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Alan Gary Friedman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Alan Gary Friedman, OD
1950 Old Gallows Rd Ste 520,
Vienna, VA 22182-3970

Ph: (703) 847-8899
Dr Alan Gary Friedman, OD
7550 Teague Rd,
Hanover, MD 21076-1339

Ph: (410) 799-8067

News Archive

Interim data from Phase 2 clinical trial of sapacitabine in patients with MDS to be presented at ASCO 2010

Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Psychiatric centres needed for Iraqi children

Psychiatric illness among Iraqi children in Baghdad is such a problem that child psychiatric centres are needed, a new study has found.

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

Read more News

› Verified 6 days ago


Optometrist in Hanover, MD

Hien Pham,
Optometrist
Medicare: Medicare Enrolled
Practice Location: 7000 Arundel Mills Cir Ste 404, Hanover, MD 21076
Phone: 410-799-2770    
Maryzabeth Philip, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 7081 Arundel Mills Cir, Hanover, MD 21076
Phone: 410-579-8347    
Dr. Teresa Maria Grillo, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 7410 Windstream Cir Apt 301, Hanover, MD 21076
Phone: 443-204-3939    Fax: 888-609-9664
April Wellons, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 7000 Arundel Mills Cir, Space 229, Hanover, MD 21076
Phone: 410-799-2770    Fax: 410-799-4328
Dr. Julie Tran, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7077 Arundel Mills Cir, Hanover, MD 21076
Phone: 410-379-3016    Fax: 410-379-3125
Eyefit Vision Centers
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7550 Teague Road, Suite 114, Hanover, MD 21076
Phone: 410-799-8067    
Erica Danielle Bennehoff, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7550 Teague Rd, Suite 114, Hanover, MD 21076
Phone: 410-799-8067    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.